Recent Updates
Recently added Catalysts
DRTS Positive Sentiment

Alpha Tau Medical to Present at Jefferies Radiopharma Innovation Summit JERUSALEM

Wednesday, March 29, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Alpha Tau Medical Ltd. announced that Chief Financial Officer Raphi Levy will present at the Jefferies Radiopharma Innovation Summit in New York City on April 3, 2023. This event highlights the company's innovative alpha-radiation cancer therapy, Alpha DaRT, aimed at treating solid tumors. In addition to the presentation, Levy will also be available for individual investor meetings, providing an opportunity to discuss the company's developments further.
Price reaction · baseline $2.83 (2023-03-28 close) · hit after-hours · 1 other DRTS headline(s) in the window, move may be shared
day 0 close · peak
+5.3%
day 1
+2.5%
day 3
+4.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Alpha Tau Medical will present at a prestigious investor summit.
  • The presentation provides a platform to showcase their innovative cancer therapy.
  • Raphi Levy's engagement in 1x1 meetings can attract investor interest.

Full Press Release Details

to Present at Jefferies Radiopharma Innovation Summit
JERUSALEM, March 29, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd.
("Alpha Tau", or the "Company") (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy
Alpha DaRT , today announced that Raphi Levy, Chief Financial Officer, will
present in-person at the Jefferies Radiopharma Innovation Summit in New York City on Monday, April 3rd, 2023.
Event: Jefferies Radiopharma Innovation Summit
Date: Monday, April 3 rd , 2023
Time: 3:30-4:00 PM ET
Location: Jefferies, NY, New York
Raphi Levy will also be available
for 1x1 investor meetings at the conference. Please reach out to your Jefferies representative to schedule.
About Alpha Tau Medical, Ltd.
Founded in 2016, Alpha Tau is an Israeli medical device company that
focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. The technology
was initially developed by Prof. Itzhak Kelson and Prof. Yona Keisari from Tel Aviv University.

Frequently Asked Questions

What is Alpha Tau Medical known for?

Alpha Tau Medical is recognized for developing the Alpha DaRT, an innovative cancer therapy.

When is the Jefferies Radiopharma Innovation Summit?

The Jefferies Radiopharma Innovation Summit is on April 3rd, 2023.

Who will present at the Jefferies summit?

Raphi Levy, the Chief Financial Officer, will present at the summit.

Where is the event taking place?

The event will take place in New York City at Jefferies.

Can investors meet with Raphi Levy?

Yes, Raphi Levy will be available for one-on-one investor meetings.

ShareAdd on Google
Tags: DRTS Viatris Investor Conferences Healthcare Alpha Tau Medical radiopharma cancer therapy solid tumors
Last updated: Mar 29, 2023